EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Role of AMPK Signaling in the Neuroprotective Effects of Trehalose in Mice With a Pharmacological Model of Alzheimer’s Disease

Alexander B Pupyshev, Marina V Ovsyukova, Anna A Akopyan, Michael V Tenditnik, Tatiana A Korolenko, Nina I Dubrovina, Maria A Tikhonova

Frontiers in Bioscience-Landmark · 2026

DOI: 10.31083/fbl53657 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2026. Verfasst von Alexander B Pupyshev und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Experimental Neuroscience, Scientific Research Institute of Neurosciences and Medicine, 630117 Novosibirsk, Russia. Hauptthemen laut MEDLINE: Alzheimer Disease, Neuroprotective Agents, Trehalose, AMP-Activated Protein Kinases. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation for the Scientific Research Institute of Neurosciences and Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background:Trehalose (TRE) has demonstrated neuroprotective potential in models of Alzheimer's disease (AD)-like pathology and has been shown to activate AMP-activated protein kinase (AMPK) and induce autophagy in hepatocytes. The molecular mechanisms underlying the neuroprotective effects of TRE in the brain, including the involvement of AMPK signaling and autophagy, remain unclear. Methods:AD was modeled in C57BL/6 mice by intracerebroventricular administration of the amyloid-β (Aβ) fragment Aβ(25–35). The effects of TRE treatment (a 3% water solution in drinking water for 20 days) on AD-like pathology in the brain (frontal cortex, amygdala, and hippocampus) were assessed by immunohistochemical analysis, while cognitive function was evaluated using the passive avoidance test. AMPK activation was assessed by measuring AMPK (p-AMPK) levels in the brain and by evaluating the effects of its inhibitor dorsomorphin (DM; 10 mg/kg, i.p., 20 days, every other day for 20 days).Results:Aβ-treated mice exhibited markedly increased Aβ levels and neuroinflammatory responses in the brain, whereas levels of the autophagy marker LC3-II and p-AMPK were moderately reduced. TRE markedly reduced Aβ accumulation and neuroinflammation and restored cognitive performance to levels comparable to those of the Control group; it also increased LC3-II immunoreactivity and p-AMPK levels in the hippocampus and amygdala. DM did not abolish the neuroprotective effects of TRE but moderately inhibited AMPK in the hippocampus.Conclusions:Marked changes in brain Aβ levels and cognitive performance were not associated with either p-AMPK or autophagy marker levels, suggesting that additional mechanisms contribute to the neuroprotective effects of TRE in AD. Markers of autophagy initiation and AMPK activity responded similarly to AD modeling and TRE treatment and were positively correlated in the hippocampus, suggesting a role for AMPK in the regulation of TRE-induced hippocampal autophagy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseNeuroprotective AgentsTrehaloseAMP-Activated Protein KinasesAnimalsMiceDisease Models, AnimalSignal TransductionMaleMice, Inbred C57BLAutophagyAmyloid beta-PeptidesBrainHippocampusCognitionPyrazolesPyrimidines

Stichwörter der Autor:innen

AMPKAlzheimer’s diseaseLC3-IIamyloid-βautophagybraindorsomorphinmicepassive avoidance testtrehalose

Substanzen

Neuroprotective AgentsTrehaloseAMP-Activated Protein KinasesAmyloid beta-PeptidesdorsomorphinPyrazolesPyrimidines

Autor:innen und Institutionen

  • Laboratory of Experimental Neuroscience, Scientific Research Institute of Neurosciences and Medicine, 630117 Novosibirsk, Russia.

Förderung

  • Ministry of Science and Higher Education of the Russian Federation for the Scientific Research Institute of Neurosciences and Medicine

Zitieren

APA

Pupyshev, A. B., Ovsyukova, M. V., Akopyan, A. A., Tenditnik, M. V., Korolenko, T. A., Dubrovina, N. I., & Tikhonova, M. A. (2026). Role of AMPK Signaling in the Neuroprotective Effects of Trehalose in Mice With a Pharmacological Model of Alzheimer’s Disease. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl53657

Vancouver

Pupyshev AB, Ovsyukova MV, Akopyan AA, Tenditnik MV, Korolenko TA, Dubrovina NI, et al. Role of AMPK Signaling in the Neuroprotective Effects of Trehalose in Mice With a Pharmacological Model of Alzheimer’s Disease. Frontiers in Bioscience-Landmark. 2026. doi:10.31083/fbl53657

BibTeX
@article{Pupyshev2026,
  author = {Pupyshev, Alexander B and Ovsyukova, Marina V and Akopyan, Anna A and Tenditnik, Michael V and Korolenko, Tatiana A and Dubrovina, Nina I and Tikhonova, Maria A},
  title = {Role of AMPK Signaling in the Neuroprotective Effects of Trehalose in Mice With a Pharmacological Model of Alzheimer’s Disease},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2026},
  doi = {10.31083/fbl53657}
}
Kostenlos starten →